Clinical Trials Browser

Interventional × Clinical Trials, Phase II as Topic × Gastrointestinal × Clear all

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Disease Progression

NCT06861777 2025-03-11

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

Phase 2/3 Not yet recruiting

474 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

747 enrolled

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT03990532 2022-09-23

Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

Phase NA Unknown

46 enrolled

Gastrointestinal

Esophageal Neoplasms

Clinical Trials

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC

REGOMUNE

Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer